We are a global event management company that hosts an annual investor and entrepreneur conference in the medtech and health tech space in Malta, Europe, alongside multiple premier roadshow events worldwide. At MedTech World, we trust in fostering collaboration among all stakeholders to attain improved healthcare for everyone. At the heart of our mission is a strong belief that each innovative startup deserves funding, and by fostering entrepreneurship, we are contributing to a robust and sustainable healthcare environment. Join over 3,000 attendees from diverse regions including the UK, Europe, North America, Asia, the Middle East, and North Africa. Engage in unparalleled networking meetups, explore investment opportunities with top MedTech investors, and connect with startups at the forefront of transforming the medtech sector.
CEO & Co-Founder, INBRAIN Neuroelectronics
Carolina Aguilar possesses over 15 years of expertise in healthcare, particularly in Medical Devices such as Neuromodulation and Diabetes, as well as experience in consumer goods. She has a passion for cross-pollinating ideas between the scientific and Fast-Moving Consumer Goods (FMCG) worlds. Recognizing the brain as one of the most important organs, Carolina has dedicated a significant portion of her time to its study. This led her to join Medtronic, the world’s largest Medtech company, where she led the most advanced neural interface program at that time in Deep Brain Stimulation (DBS). During her tenure in DBS, which spanned a decade, Carolina managed complex businesses in this field, overseeing a Profit and Loss (P&L) of over $140 million. She led large local and global teams, achieving high single to double-digit growth percentages year-over-year. In recent years, she has also been involved in Value-Based Healthcare (VBHC), driving the expansion of the first VBHC provider model in Diabetes for Medtronic. This endeavor included signing a major deal in Saudi Arabia and winning the European VBHC prize in 2017. Carolina’s experience with VBHC reinforced her belief in delivering solutions focused on patient outcomes, leading to patient empowerment and the sustainability of healthcare. After an extensive corporate career, Carolina made the decision to contribute to critical innovation at a faster pace. She recently co-founded INBRAIN Neuroelectronics, a company operating in the field of Bioelectronics. Carolina assembled an incredible team with backgrounds in nanoscience, Medtronic, and Philips. Adhering to VBHC principles, INBRAIN Neuroelectronics is developing the next generation of neural interfaces using graphene, the material that earned the Nobel Prize for Geim and Novoselov from Manchester University in 2010. The company is a spin-off from the Graphene Flagship’s partner, the Nanoscience & Nanotechnology Institute of Catalonia (ICN2). Leveraging the unique properties of graphene, they aim to decode brain and nerve signals to create breakthrough and sustainable medical solutions.
CEO at MedTech Europe
Oliver joined MedTech Europe in 2017, originally heading the department which supports members in implementing new and changing EU regulatory requirements affecting the medical technology industry. In January 2023, Oliver assumed the role of Chief Executive Officer, responsible for the association’s overall management and strategy and reporting to the Board of Directors. Oliver’s passion is to see the value of medical technology innovation fully recognised as a source of solutions to the many challenges facing healthcare systems, economies and societies, both in Europe and around the world. Prior to joining MedTech Europe, he worked at Medtronic as Director of Regulatory Policy for EMEA. In addition to this company experience, Oliver had various trade association roles in Brussels, at COCIR (the European association for the radiological, electromedical and healthcare IT industries) and at EDANA (the industry association for the nonwovens and related industries). Oliver is a native speaker of English, and a dual national of Australia and Malta. When not working, he enjoys travel, spending time with his family, and rock-climbing.
Managing Partner, Catalyst Health Ventures
Darshana is Co-Founder and Managing Partner of Catalyst Health Ventures. She is actively involved in all aspects of fund management and has led CHV’s investments in the medical device and diagnostics markets. Darshana currently serves as an advisor of the Deshpande Center for Technological Innovation at MIT, as a Board Director of the New England Venture Capital Association and as a lead advisor to the Portfolia FemTech Fund.
Ina Laura Perkins
CEO, Scandinavian Real Heart
I am a biomedical scientist and entrepreneur with commercialisation experience in the start-up phase in the field of regenerative medicine and medical devices. My background is a mix of applied research focused on product development and business development of biomedical innovations. I have worked with biotechnology and pharmaceuticals, stem cells, and medical devices. My expertise ranges from developing products from the idea stage to proof of concept and the non-clinical development stage. Having worked in various start-ups for 15 years, I am used to wearing many hats and have developed a broad range of commercials skills including commercial technology appraisal, intellectual property portfolio management (freedom to operate analysis, patent filing), securing funding (academic and government grants, venture capital), and expanding and promoting research (academic publications, conference presentations). Currently I manage the development of a novel total artificial heart, the Realheart TAH, focusing on minimising the impact caused by shear stress and foreign materials on the blood cells and proteins.
Joseph W. Rafferty
CEO & Founder at VESTECK Inc.
VESTECK is a clinical stage endovascular platform technology in the aortic repair, structural heart and surgical markets. The “Suture-Tight”tm catheter delivers preloaded nitinol sutures to EVAR/TEVAR endovascular grafts securing the grafts to the aorta, either at the time of initial implant or reintervention. Global opinion leaders tell us that the “Suture-Tight”tm will bring significant benefit to patients, physicians and payors. Mr. Rafferty has leveraged his education with global strategic organizations like ACS/Guidant, CR Bard and J&J Ethicon, to create value, bringing novel technology to the global health care community at startup companies like Pathway Medical, NMS and VESTECK. Mr. Rafferty is a proud graduate of The Temple University, Philadelphia, PA. He and his wife Beth are the proud parents of 4 wonderful children and 4 beautiful grandchildren.
Operating Partner & CBO at Truffle Capital
CEO at NXgenPort Inc
CATHY SKINNER, CEO is an Executive Healthcare leader with 20+ years of successful experience building businesses, differentiated products, and services that manage healthcare costs and improve patient outcomes.
Founder and CEO at Alverium Health
Julie is a C-level industry expert with 25+ years dedicated to corporate growth leadership with experiences ranging from early clinical development through commercialization across pharmaceutical, biotech, and device sectors. Her achievements are based on delivering consistent, above market growth for global and regional initiatives, corporate marketing, and complete life cycle brand management.
Co-founder and COO, Robeauté
With 10+ years in operational roles in deep-tech projects, Joana Cartocci has a multidisciplinary and multicultural background. Her career spans from linguistics and international relations to coordination roles in deeptech projects that bridge tech, citizen movement, art, well-being and politics. In 2017, she co-founded Robeauté with Bertrand Duplat, to create the next generation smart neurosurgical delivery device to better understand and treat brain pathologies.
Venture Partner at Wavemaker Three-Sixty Health
Kwame Ulmer is a venture partner at Wavemaker Three-Sixty Health. He leads the medtech practice and participates in all aspects of fund management (e.g. deal sourcing, diligence, negotiation, and advising portfolio company management teams)
CEO, Vivasure Medical
Andrew Glass is the CEO of Vivasure Medical, an innovative medical device start-up based in Ireland. Previous to Vivasure, Andrew was a senior executive at Abbott Laboratories for over fifteen years. He has significant multi-cultural leadership experience in Asia, Europe, and the United States. Andrew holds a BSE in Chemical Engineering from Princeton University and an MBA from the Harvard Business School.
Senior Investment Manager at Sagana
Sanchita Pasi is a Senior Investment Manager at Sagana with a Pharm.D and an MBA from SDA Bocconi. Sanchita’s experience spans across international MedTech product management and commercialization from her time at Abbott Laboratories. She then transitioned to venture capital starting at Nina Capital and now impact investing at Sagana. She is excited to meet founders who are need-driven and fueled by the goal to improve access and affordability for healthcare worldwide. She has indian roots, a mediterranean upbringing, and is also a painter by night.
CEO & Co-Founder at Vonova
Wesley Jones, MBA MS, is a Biodesign fellow and medical device engineer specialized in the development of minimally invasive, catheter-based, technology. Mr. Jones has spent a decade leading technical teams from concept to commercialization and has successfully launched 11 devices to market at Medtronic and Acutus Medical.
CEO and Co-Founder at PanTher Therapeutics
Technology Development Manager, Mayo Clinic Ventures
Brittany Barreto, PhD
Chief Innovation Officer, FemHealth Insights
Dr. Barreto is a global key opinion leader in women’s health innovation and widely known as the Voice of FemTech. She is a Molecular Geneticist by training with experience founding and investing in startups. She is founder of FemHealth Insights and host of the FemTech Focus podcast.
Co-Founder & Venture Partner, Early Bird Medical & ShangBay Capital
Michael is a medical device executive, serial entrepreneur, inventor, and part-time venture capitalist. He has a passion for commercializing disruptive technologies that help patients.He has co-founded 5 companies with 4 successful exits to date. Most recently, in 2021, Michael sold Devoro Medical to Boston Scientific.
CEO, Pixium Vision
Lloyd Diamond, a US citizen, is a seasoned medtech executive and CEO with 25 years of disruptive technology commercialization experience in the life science industry. He most recently served as the CEO of Precise Light Surgical, a commercially ready medical device company in Silicon Valley. Prior to that, he was the CEO of Bonesupport AB, a European orthobiologic company, where he drove rapid market penetration in Europe and the US which led to a successful IPO on the NASDAQ OMX in Stockholm. Lloyd has first-hand experience in the ophthalmology segment as he was responsible for managing Lumenis’ global surgical and vision franchises. He has commercialized many other disruptive technology platforms including at Kyphon and Laserscope. Lloyd received a dual degree in Biochemistry and Marketing from Florida Atlantic University and an MBA from the Thunderbird School of Global Management at Arizona State University.
CEO at Vibrato Medical
Juliana is a CEO, board member, entrepreneur, and advisor with over 20 years of experience bringing medtech innovation to patients in startup to multi-billion-dollar companies. Over the course of her career Juliana has created companies, facilitated exits doubling shareholder expectations, and developed strategies to grow a billion-dollar business at 15+%.
Managing Director at Rex Health Ventures
Anita manages Rex Health Ventures (RHV), the corporate venture fund of UNC Health, the largest academic health system serving the state of North Carolina. RHV’s mission is to spur innovation in healthcare through equity investment and partnership with emerging health companies. She currently serves on the boards of Bio54, Biostable Science and Engineering, ReDiscovery Life Sciences, Vergent Bioscience, and Censinet.
Josep LI. Sanfeliu
Managing Partner & Co-founder, Asabys Partners
Josep has more than 15 years of experience as VC, first co-founding Ysios Capital in 2008 and more recently founding Asabys Partners in 2018 which is managing close to € 300 Mio in health innovation investments. He has specialized in life sciences and healthtech investments in Europe, Israel and the US with more than 10 investments and Boards in the space and some successful exits. Previously he has had a hybrid career in law and finance in the pharma and healthcare world working for Cuatrecasas, KPMG, DomusVi and Almirall. Josep has a Law Degree from Universitat Pompeu Fabra, a Master of Laws from University of Michigan and an MBA from IESE Business School.
Founder at Ravn Partners LLC
Rachel Offenburg is a passionate advocate for the growth and success of biotech and life science startups. Her entrepreneurial spirit and commitment to this dynamic sector shine through in her role as a consultant, where she has carved out a niche in providing invaluable business strategy support to early-stage ventures.Rachel assists startups in charting their course to commercialization with her expertise in fundraising and investor strategy, a critical aspect of any budding startup venture’s journey. Rachel’s proficiency in business development helps startups forge essential partnerships and collaborations that can drive innovation and growth. Rachel has a master of business administration (MBA) from the University of Virginia Darden School of Business, with a focus on entrepreneurship, and a BS in biology and business from Emmanuel College.
Aashiish Agnihotri, PhD
Founder & CEO, xDot Medical Inc
Co-Founder & Vice President, HighLife
Co-founder of HighLife, a Cardiovascular Medtech company based in Paris and California, Malek has a biomechanical engineering background. He has developed a Transcatheter Mitral Valve Replacement technology from early concept to production. After conducting pre-clinical testing then First In Human implant, he is now leading Therapy Development and clinical implementation globally.
A unique opportunity for entrepreneurs to gain exposure, receive feedback, and secure funding for their ventures
What others have to say after experiencing MedTech Malta 2023
Venture Partner, Wavemaker Three-Sixty Health
Partner & Co-Head MedTech Practice, Group Goodwin Procter
Founder & CEO, Alverium Health
Principal, 415 Capital Management GmbH
Founder & Managing Partner, Solardis Health Ventures
CEO, Pixium Vision
Managing Director, PTL Limited
CEO, MedTech Europe
Dr. Sanjay Shrivastava
CEO, Innova Vascular, Inc.
Expand Your Network with MedTech Match
Notable Early SaMD Cleared by FDA
Breaking boundaries: 5-HT and MedTech World form partnership ahead of Berlin Roadshow
Revolutionizing Healthcare: Lapsi Health’s Sound-Based Technology earns ISO 13485 Seal of Excellence